X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

EVO

Closed

Evotec Se Adr

4.22
+0.02 (+0.48%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 4.2
Day's Range: 4.16 - 4.29
Send
When Written:
 
10.4501
Evotec SE is a German drug discovery and development company that focuses on developing drugs for diseases in areas such as neuroscience, oncology, and infectious diseases. The company was founded in 1993 and is headquartered in Hamburg, Germany.

Evotec SE has an American Depositary Receipt (ADR) program, which allows investors to invest in the company's shares through the US securities market. Each ADR represents one ordinary share of Evotec SE, and the ADRs are traded on the NASDAQ Global Select Market under the ticker symbol "EVTCY".

As of August 2021, Evotec SE has a market capitalization of around $8.5 billion and employs over 3,000 people worldwide. The company has partnerships with numerous pharmaceutical and biotech companies, including Bayer, Sanofi, and Takeda, and has a strong pipeline of drug candidates in various stages of development.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X